![Julie Dechanet-Merville](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Julie Dechanet-Merville
Direktor/Vorstandsmitglied bei Lymphact - Lymphocyte Activation Technologies SA
Aktive Positionen von Julie Dechanet-Merville
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Lymphact - Lymphocyte Activation Technologies SA
![]() Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Julie Dechanet-Merville
Statistik
International
Portugal | 2 |
Operativ
Director/Board Member | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Lymphact - Lymphocyte Activation Technologies SA
![]() Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | Health Technology |
- Börse
- Insiders
- Julie Dechanet-Merville
- Erfahrung